BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6624623)

  • 1. [The value of counterimmunoelectrophoresis for the assay of prostatic acid phosphatase].
    Lamy S; Borsi C; Humbel R
    Acta Urol Belg; 1983; 51(3):340-4. PubMed ID: 6624623
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative counterimmunoelectrophoresis assay for prostatic acid phosphatase.
    Killian CS; Vargas FP; Lee CL; Wang MC; Murphy GP; Chu TM
    Invest Urol; 1980 Nov; 18(3):219-24. PubMed ID: 7429782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of prostatic acid phosphatase assays.
    Wise WS; Kandaswamy K
    Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay versus counterimmune electrophoresis for measurement of serum prostatic acid phosphatase.
    Wright GL; Schellhammer PF; Leffell MS; Sieg SM; Brassil BN
    Urology; 1982 Apr; 19(4):351-5. PubMed ID: 7072025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow acid phosphatase in prostate cancer: an assessment by immunoassay and biochemical methods.
    Romas NA; Veenema RJ; Hsu KC; Tomashefsky P; Lattimer JK; Tannenbaum M
    Trans Am Assoc Genitourin Surg; 1979; 71():26-30. PubMed ID: 545810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic cancer. Immunochemical detection of prostatic acid phosphatase in serum and bone marrow.
    Catane R; Madajewicz S; Wajsman ZL; Chu TM; Mittelman A; Murphy GP
    N Y State J Med; 1978 Jun; 78(7):1060-1. PubMed ID: 275612
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone marrow acid phosphatase concentrations in individuals with prostatic carcinoma or other disorders.
    Little C; Shojania AM; Green PT; Weinerman BH
    Can Med Assoc J; 1978 Aug; 119(3):259-61. PubMed ID: 679131
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relation of serum levels of acid phosphatase in the femoral vein and the inferior vena cava in adenocarcinoma of the prostate].
    De Arruda HO; Srougi M; Wroklawski E; Mello Júnior OM; De Góes GM
    Rev Paul Med; 1981; 97(7-9):113-5. PubMed ID: 7342295
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of countercurrent immunoelectrophoretic assay with commercial radioimmunoassay kits for measuring prostatic acid phosphatase.
    Wright GL; Schellhammer PF; Brassil DN; Sieg SM; Leffell MS
    Clin Chem; 1981 Oct; 27(10):1747-52. PubMed ID: 6169470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic acid phosphatase: current concepts.
    Romas NA
    Semin Urol; 1983 Aug; 1(3):177-85. PubMed ID: 6379804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acid phosphatase in the bone marrow: diagnostic value in prostatic carcinoma].
    Tenaillon M; Billon B; Kelly A; Toppercer A; Elhilali MM
    J Urol (Paris); 1980; 86(2):107-10. PubMed ID: 7452042
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum aldolase in prostatic cancer].
    Maganto-Pavón E; Isorna S; Navajo-Galindo JA; Daimiel-Fernández ER; Martínez-Piñeiro JA
    Actas Urol Esp; 1979; 3(4):227-30. PubMed ID: 484308
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical and immunologic techniques for acid phosphatase measurement in the diagnosis of prostate cancer.
    Chu TM
    Natl Cancer Inst Monogr; 1978 Dec; (49):239. PubMed ID: 748777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State of the art in immune diagnosis of early adenocarcinoma of the prostate.
    Pontes JE
    Urol Clin North Am; 1980 Oct; 7(3):667-74. PubMed ID: 7456178
    [No Abstract]   [Full Text] [Related]  

  • 15. Human prostatic acid phosphatases: III. Counterimmunoelectrophoresis for rapid identification.
    McDonald I; Rose NR; Pontes EJ; Choe BK
    Arch Androl; 1978 May; 1(3):235-9. PubMed ID: 83816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two new, direct, and specific methods of acid phosphatase determination. National field trial.
    Wajsman Z; Chu TM; Saroff J; Slack N; Murphy GP
    Urology; 1979 Jan; 13(1):8-11. PubMed ID: 442328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of determining prostatic acid phosphatases by a radioimmunological method in cases of bony metastases].
    Mattei JP; Imbert I; Laugier-Catenacci E; Roux H
    Rev Rhum Mal Osteoartic; 1989 Feb; 56(2):147-9. PubMed ID: 2471253
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of serum aldolase in the early diagnosis of prostatic carcinoma].
    Maganto Pavón E; Daimiel Fernández ER; Navajo Lindo JA; Isorna S; Martínez Piñeiro JA
    Rev Clin Esp; 1979 Feb; 152(3):227-30. PubMed ID: 441476
    [No Abstract]   [Full Text] [Related]  

  • 19. Occult carcinoma of the prostate.
    El-Morsi AR
    J Egypt Med Assoc; 1974; 57(7-8):373-7. PubMed ID: 4452775
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of prostatic acid phosphatase assay as a tumor marker].
    Kuriyama M; Takahashi Y; Kawada Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():925-7. PubMed ID: 2355633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.